The chief compliance officer of a Florida pharmacy holding company faces up to 20 year’s imprisonment after a federal jury convicted him of fraudulently billing Medicare over $50 million today.
According to court documents and evidence presented at trial, Steven King was the chief compliance officer of a pharmacy holding company that fraudulently billed Medicare over $50 million for dispensing lidocaine and diabetic testing supplies that Medicare beneficiaries did not need or want. King and his co-conspirators operated A1C Holdings LLC, which held pharmacies in various states, including All American Medical Pharmacy in Warren, Michigan. When A1C secured prescriptions and refills on behalf of its pharmacies for medically unnecessary lidocaine and diabetic testing supplies, the jury found they violated Medicare and pharmacy benefit manager rules.
King and his co-conspirators took several steps to conceal their scheme, including enrolling their mail order pharmacies as brick-and-mortar retail locations to evade more rigorous oversight, shipping prescription refills for high-reimbursing medications and supplies without patient consent, concealing the ownership of A1C Holdings LLC and its pharmacies, and transferring patients among pharmacies without patient consent. The Justice Department charged King and his co-conspirators took each of these steps to continued billing Medicare for profitable medications and supplies.
As chief compliance officer, King was in a unique position to prevent and report the fraudulent scheme, but he used his position to defraud Medicare instead.
The jury convicted King of conspiracy to commit health care fraud and wire fraud. His sentencing is scheduled for September 14. He faces a maximum penalty of 20 years in prison.
For More Information
We hope this update is helpful. For more information about these or other health or other legal, management or public policy developments, please contact the author Cynthia Marcotte Stamer via e-mail or via telephone at (214) 452 -8297.
Solutions Law Press, Inc. invites you to receive future updates by registering on our Solutions Law Press, Inc. Website and participating and contributing to the discussions in our Solutions Law Press, Inc. LinkedIn SLP Health Care Risk Management & Operations Group, HR & Benefits Update Compliance Group, and/or Coalition for Responsible Health Care Policy.
About the Author
Recognized by her peers as a Martindale-Hubble “AV-Preeminent” (Top 1%) and “Top Rated Lawyer” with special recognition LexisNexis® Martindale-Hubbell® as “LEGAL LEADER™ Texas Top Rated Lawyer” in Health Care Law and Labor and Employment Law; as among the “Best Lawyers In Dallas” for her work in the fields of “Labor & Employment,” “Tax: ERISA & Employee Benefits,” “Health Care” and “Business and Commercial Law” by D Magazine, Cynthia Marcotte Stamer is a practicing attorney board certified in labor and employment law by the Texas Board of Legal Specialization and management consultant, author, public policy advocate and lecturer widely known for 35 plus years of health industry and other management work, public policy leadership and advocacy, coaching, teachings, and publications.
A Fellow in the American College of Employee Benefit Counsel, Chair of the American Bar Association (“ABA”) International Section Life Sciences and Health Committee, Chair-Elect of the ABA TIPS Section Medicine & Law Committee, Past Chair of the ABA Managed Care & Insurance Interest Group, Scribe for the ABA JCEB Annual Agency Meeting with HHS-OCR, past chair of the ABA RPTE Employee Benefits & Other Compensation Group and current co-Chair of its Welfare Benefit Committee, Ms. Stamer is most widely recognized for her decades of pragmatic, leading-edge work, scholarship and thought leadership on health and managed care and employer benefits legal, public policy and operational concerns in the healthcare, employer benefits, and insurance and financial services industries. She speaks and publishes extensively on HIPAA and other related compliance issues.
Ms. Stamer’s work throughout her career has focused heavily on working with health care and managed care, health and other employee benefit plan, insurance and financial services and other public and private organizations and their technology, data, and other service providers and advisors domestically and internationally with legal and operational compliance and risk management, performance and workforce management, regulatory and public policy and other legal and operational concerns.
For more information about Ms. Stamer or her health industry and other experience and involvements, see www.cynthiastamer.com or contact Ms. Stamer via telephone at (214) 452-8297 or via e-mail here.
About Solutions Law Press, Inc.™
Solutions Law Press, Inc.™ provides human resources and employee benefit and other business risk management, legal compliance, management effectiveness and other coaching, tools and other resources, training and education on leadership, governance, human resources, employee benefits, data security and privacy, insurance, health care and other key compliance, risk management, internal controls and operational concerns. If you find this of interest, you also be interested in reviewing some of our other Solutions Law Press, Inc.™ resources available here such as:
- OCR Sanction Of 44th Health Care Provider For Violating HIPAA Right of Access Rules Warning To Other Covered Entities
- Medical Center’s Overtime Award Highlights FLSA Risks For Health Industry Employers
- HHS Prepares To End COVID Vaccine Mandate
- Medical Professionals, Medical Businesses Owners and Others Criminally Charged In $490 Million Plus COVID-19 Related False Billings Takedown
- Sibley Hospital & Johns Hopkins Health System Pay $5 Million To Settle Stark Violations
- Sibley Hospital & Johns Hopkins Health System Pay $5 Million To Settle Stark Violations
- HHS Inspector General Comments Signal MorrContinuAggressive Ahghinued Aggresdiv
- 4/21 Deadline For Comments On Proposed HIPAA Administrative Simplification Adoption of Standards for Health Care Attachments Transactions and Electronic Signatures, and Modification To Referral Certification and Authorization Transaction Standard
- Pharmaceutical Distributor Danco’s $765,000 False Claims Act Settlement Shows Importance Of Customs Marking and Duty Rules
- $400K EEOC Settlement Warns Health Care Organizations Against Pregnancy Discrimination
- 2 Pharmacy FCA Convictions WarnAgainst Billing Or Undelivered Drugs Or Care
- “Rock Doc” Opioid Conviction Reaffirms DOJ Prioritization & Frequent Success of Illegal Opioid Distribution Enforcement
- Health Care Provider Pays $4 Million For Making Prohibited Donations Toward County Medicaid Funding
- OIG Asks Cigna MA Plans To Refund $6 Million, Clean Up Plan Processes After Poor Audit Results
- FY 2022 Medicaid Fraud Conviction Increase, Other Data Shows Continued Robustness of Federal Medicaid Enforcement
- Health Care Providers Should Verify Compliance, Audit Risks In Preparation For End of COVID Flexibilities
- Prepare To Handle Justice Department Marijuana Pardon Certificates From Applicant
- Sentencings & Charges Of Clinic Operators For Defrauding Health Plans Highlight Risks Of Involvement In Schemes To File Fraudulent Health Benefit Claims
- Former Missouri Lawmaker Sentenced On COVID & Stem Cell Fraud, Illegally Distributing Prescription Drugs & False Statements
- Ensure Health Care & Other Compliance Practices Updated For New DOJ Voluntary Disclosure Policy
- F-1 Visa Guidance Could Impact Health Industry Work Eligibility Of Some Foreign Students
- DOJ Withdraws Health Care Antitrust Policy & Enforcement Statements
IMPORTANT NOTICE ABOUT THIS COMMUNICATION
If you or someone else you know would like to receive future updates about developments on these and other concerns, please be sure that we have your current contact information including your preferred e-mail by creating your profile here.
NOTICE: These statements and materials are for general informational and educational purposes only. They do not establish an attorney-client relationship, are not legal advice or an offer or commitment to provide legal advice, and do not serve as a substitute for legal advice. Readers are urged to engage competent legal counsel for consultation and representation in light of the specific facts and circumstances presented in their unique circumstances at any particular time. No comment or statement in this publication is to be construed as legal advice or an admission. The author and Solutions Law Press, Inc.™ reserve the right to qualify or retract any of these statements at any time. Likewise, the content is not tailored to any particular situation and does not necessarily address all relevant issues. Because the law is rapidly evolving and rapidly evolving rules make it highly likely that subsequent developments could impact the currency and completeness of this discussion. The author and Solutions Law Press, Inc.™ disclaim, and have no responsibility to provide any update or otherwise notify anyone of any such change, limitation, or other condition that might affect the suitability of reliance upon these materials or information otherwise conveyed in connection with this program. Readers may not rely upon, are solely responsible for, and assume the risk and all liabilities resulting from their use of this publication. Readers acknowledge and agree to the conditions of this Notice as a condition of their access to this publication.
Circular 230 Compliance. The following disclaimer is included to ensure that we comply with U.S. Treasury Department Regulations. Any statements contained herein are not intended or written by the writer to be used, and nothing contained herein can be used by you or any other person, for the purpose of (1) avoiding penalties that may be imposed under federal tax law, or (2) promoting, marketing or recommending to another party any tax-related transaction or matter addressed herein.
©2023 Cynthia Marcotte Stamer. Limited non-exclusive right to republish granted to Solutions Law Press, Inc.™

This is a well-written and informative blog post. It is concerning to read about the fraudulent scheme to bill Medicare for unnecessary medications and supplies. My question is, what steps can be taken to prevent future occurrences of such fraudulent schemes and hold those involved accountable? Thank you for sharing this informative blog post. As a reader, I appreciate learning about these important issues affecting the healthcare industry. My question is, what measures can be taken to prevent fraudulent schemes like this from happening in the future and ensure those involved are held accountable?
There are a multitude of current federal and state activities targeting healthcare fraud. Unfortunately, the investments, disproportionately focus on nitpicky and often unreasonable harassment of healthcare providers well failing to identify and address, obvious fraudster, such as the one covered in this article.
Currently, most fraud detection and enforcement efforts are focused on creating often times retroactively hypertext, Michol guidance, and then auditing and enforcing it against physicians and other healthcare providers operating in good faith, but without a proper understanding of these hypertechnical, and often times late arriving rules. The government spends an extraordinary amount of money, directly and through its multiple levels of auditors to identify these technical Gochie claims and go after physicians and others, while ignoring obvious fraud such as this. Meanwhile provider cost, and the resulting cost of patients in the insert system are driven up by these misdirected fraud activities. Basically, the government needs to re-think it’s definition of fraud. It is allowed the industry for audits to become the mass, consumer of most of our healthcare, dollars at the expense of care while facilitating fraud such as this by actual fraudsters.
If the government redefined fraud wouldn’t they also become targets? Thank you for your answer and exposing the problem.